Abstract:Background: Ubiquitin C-terminal hydrolase L1 (UCHL1), which encodes thiol protease that hydrolyzes a peptide bond at the C-terminal glycine residue of ubiquitin, regulates cell differentiation, proliferation, transcriptional regulation, and numerous other biological processes and may be involved in lung cancer progression. UCHL1 is mainly expressed in the brain and plays a tumor-promoting role in a few cancer types; however, there are limited reports regarding its role in lung cancer. Methods: Single-cell RNA (scRNA) sequencing using 10X chromium v3 was performed on a paired normal-appearing and tumor tissue from surgical specimens of a patient who showed unusually rapid progression. To validate clinical implication of the identified biomarkers, immunohistochemical (IHC) analysis was performed on 48 non-small cell lung cancer (NSCLC) tissue specimens, and the correlation with clinical parameters was evaluated. Results: We identified 500 genes overexpressed in tumor tissue compared to those in normal tissue. Among them, UCHL1, brain expressed X-linked 3 (BEX3), and midkine (MDK), which are associated with tumor growth and progression, exhibited a 1.5-fold increase in expression compared to that in normal tissue. IHC analysis of NSCLC tissues showed that only UCHL1 was specifically overexpressed. Additionally, in 48 NSCLC specimens, UCHL1 was specifically upregulated in the cytoplasm and nuclear membrane of tumor cells. Multivariable logistic analysis identified several factors, including smoking, tumor size, and high-grade dysplasia, to be typically associated with UCHL1 overexpression. Survival analyses using The Cancer Genome Atlas (TCGA) datasets revealed that UCHL1 overexpression is substantially associated with poor survival outcomes. Furthermore, a strong association was observed between UCHL1 expression and the clinicopathological features of patients with NSCLC. Conclusion: UCHL1 overexpression was associated with smoking, tumor size, and high-grade dysplasia, which are typically associated with a poor prognosis and survival outcome. These findings suggest that UCHL1 may serve as an effective biomarker of NSCLC.

Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is Associated with Tumour Aggressiveness and Poor Prognosis in Human Non-Small Cell Lung Cancer.

CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

CTHRC1 Overexpression Predicts Poor Survival and Enhances Epithelial‐mesenchymal Transition in Colorectal Cancer

CTHRC1 Induces Non-Small Cell Lung Cancer (NSCLC) Invasion Through Upregulating MMP-7/MMP-9

The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis

High expression of Cullin1 indicates poor prognosis for NSCLC patients.

Expression and clinical significance of collagen triple helix repeat containing 1 in cervical cancer

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers

Elevated Expression of Cthrc1 Predicts Unfavorable Prognosis in Patients with Pancreatic Ductal Adenocarcinoma

High Expression of CTHRC1 Promotes EMT of Epithelial Ovarian Cancer (EOC) and is Associated with Poor Prognosis

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma

Cthrc1 Promotes Human Colorectal Cancer Cell Proliferation and Invasiveness by Activating Wnt/Pcp Signaling

Application Potential of <i>CTHRC1</i> as a Diagnostic and Prognostic Indicator for Colon Adenocarcinoma

<i>CTHRC1</i>is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer

The role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression

CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.

UCHL1 Overexpression Is Related to the Aggressive Phenotype of Non-small Cell Lung Cancer

CTHRC1, a novel gene with multiple functions in physiology, disease and solid tumors (Review)

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma

Upregulated Cthrc1 Promotes Human Epithelial Ovarian Cancer Invasion Through Activating Egfr Signaling